HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.

Abstract
We determined the concentrations of goblet and immune cells in conjunctival imprints and tissues of canines with keratoconjunctivitis sicca (KCS) before and after cyclosporine A (CsA) treatment. Twelve dogs with bilateral KCS were assigned to three groups: untreated, treatment group 1, and treatment group 2. The treatment groups were treated topically with 2% ophthalmic CsA solution for 45 days; CsA treatment group 2 was followed for an additional 30 days after discontinuation of the drug. Schirmer tear test (STT) scores were recorded prior to CsA treatment and on alternate days throughout the experiment. CsA treatment improved the STT scores, restored conjunctival histology, increased goblet and epithelial cell numbers, and decreased numbers of inflammatory cells. Although the STT scores regressed slightly at day 30 after discontinuing the treatment, the scores were higher than the baseline values. Topical CsA treatment resolved clinical signs of KCS, improved STT scores and restored normal conjunctival histology.
AuthorsC Izci, I Celik, F Alkan, M Erol, E Sur
JournalBiotechnic & histochemistry : official publication of the Biological Stain Commission (Biotech Histochem) Vol. 90 Issue 3 Pg. 223-30 (Apr 2015) ISSN: 1473-7760 [Electronic] England
PMID25747049 (Publication Type: Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Cyclosporine
Topics
  • Administration, Topical
  • Animals
  • Biopsy
  • Conjunctiva (pathology)
  • Cyclosporine (therapeutic use)
  • Dog Diseases (drug therapy, pathology)
  • Dogs
  • Female
  • Immunity, Mucosal
  • Immunosuppressive Agents (administration & dosage, therapeutic use)
  • Keratoconjunctivitis Sicca (drug therapy, pathology, veterinary)
  • Lymphocyte Subsets (pathology)
  • Male
  • Mast Cells (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: